Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.972
+0.012 (0.60%)
Nov 21, 2024, 11:39 AM EST - Market open
Caribou Biosciences Stock Forecast
CRBU's stock price has decreased by -62.45% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 14, with a low estimate of 9.00 and a high estimate of 19. The average target predicts an increase of 610.05% from the current stock price of 1.97.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRBU stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +356.46% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +356.46% | Sep 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +356.46% | Aug 14, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $14 | Buy | Reiterates | $14 | +610.05% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +356.46% | Jul 17, 2024 |
Financial Forecast
Revenue This Year
11.65M
from 34.48M
Decreased by -66.22%
Revenue Next Year
10.35M
from 11.65M
Decreased by -11.15%
EPS This Year
-1.80
from -1.38
EPS Next Year
-2.08
from -1.80
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.2M | 14.7M | 226.5M | ||
| Avg | 11.6M | 10.3M | 73.3M | ||
| Low | 5.8M | n/a | 9.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -50.1% | 26.2% | 2,089.3% | ||
| Avg | -66.2% | -11.1% | 608.5% | ||
| Low | -83.2% | - | -5.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.73 | -1.72 | -0.69 | ||
| Avg | -1.80 | -2.08 | -1.78 | ||
| Low | -1.90 | -2.85 | -2.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.